Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
3.170
+0.150 (4.97%)
Jun 23, 2026, 3:00 PM CST
Market Cap2.07B -55.0%
Revenue (ttm)173.47M -33.9%
Net Income-316.00M
EPS-0.47
Shares Out 651.90M
PE Ration/a
Forward PEn/a
Dividend0.08 (2.47%)
Ex-Dividend DateJul 15, 2025
Volume15,045,200
Open3.000
Previous Close3.020
Day's Range2.990 - 3.170
52-Week Range2.860 - 7.810
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 340
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

Financial Statements